Amicus Therapeutics, Inc. (FOLD) Highlights Data Featured At Lysosomal Disease Network WORLD Symposium 2014
2/12/2014 9:17:36 AM
CRANBURY, N.J., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today summarized the key highlights from 2 oral platform presentations featuring its Pompe and Fabry programs at the Lysosomal Disease Network WORLD Symposium (LDN WORLD) 2014. LDN WORLD is taking place in San Diego, CA from February 10-13, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by